Pediatrix Medical Group, Inc. (MD) stock
MDNYSEServices-HospitalsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 10/305% above fair value
$31.89+0.59 (+1.88%)
Close on Nov 16, 2026Market cap $2.49BP/E 17.3Yield –
Pediatrix Medical r&d expenses
Research and development expenses are spending on new products and technology.
No r&d expenses figures for Pediatrix Medical
Pediatrix Medical has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?